Study of Safety and Efficacy on New Peritoneal Dialysis Solutions
Status:
Withdrawn
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
A major challenge of peritoneal dialysis (PD) therapy is the development of glucose-sparing
strategies able to provide an efficacious ultrafiltration (UF) profile. Study hypothesis is
to evaluate the possibility to formulate PD solutions containing xylitol and L-carnitine as
osmotic agents to partially replace glucose.